简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-07-12 08:27 HDFC Bank Spends Rs. 634.91 Cr Towards CSR in FY 2020-2021
2021-07-12 08:22 New Data from the Phase 3 HELP Study™ Open-Label Extension Evaluating Safety and Efficacy of TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress
2021-07-09 14:24 Philip Morris International Inc. Announces Firm Offer to Acquire Vectura Group plc; Acquisition Accelerates PMI’s Beyond Nicotine Strategy and Expands its Product Pipeline Development Capabilities in Inhaled Therapeutics
2021-07-09 10:00 Kyalio Launches Day-to-Day Endo-Laparoscopic VR Surgical Library, the First in Asia
2021-07-08 20:08 New Survey by Patient Safety Movement Foundation Reveals Only Forty-Five Percent of Patients Feel in Control of Their Health
2021-07-08 14:46 Reversal of Aging of Human Cartilage, Restoring Youthfulness; the First of Its Kind Feat by Edogawa Hospital, Japan.
2021-07-08 09:44 Waters to Help Accelerate Biologics Production Through Research Collaboration With Singapore’s Bioprocessing Technology Institute
2021-07-07 19:30 Alvotech Initiates Clinical Studies for AVT04, a Proposed Biosimilar to Stelara® (Ustekinumab)
2021-07-07 16:00 New Study Evaluates the Ability of Masimo SedLine® Brain Function Monitoring to Predict Neurological Outcomes and Long-term Survival in Post-Cardiac Arrest ICU Patients
2021-07-07 09:40 Breakthrough results for empagliflozin confirm EMPEROR-Preserved as first and only successful trial for heart failure with preserved ejection fraction
2021-07-06 19:00 Allurion Technologies Unveils Transformed Allurion™ Weight Loss Program and New Corporate Brand
2021-07-05 11:26 Sentrx™ Animal Care, Inc. Announces Manufacturing Facility Expansion to Accommodate Accelerated Growth
2021-07-02 10:37 Solasia Announces Submission of New Drug Application for Anti-cancer Drug DARINAPARSIN for Peripheral T-Cell Lymphoma in Japan
2021-07-02 09:49 LG Chem Announces Topline Results of LC350189 From the Phase 2 Study (CLUE Study) Promising to Be a New Treatment Alternative With Improved Efficacy and Safety Profiles for Chronic Gout Patients
2021-07-01 20:18 SpeeDx and MolGen Announce Partnership for COVID-19 Test Solution
2021-07-01 20:07 Imperva® Names George Lee as Regional Vice President, Asia Pacific and Japan
2021-07-01 19:58 Convert Group Study: COVID-19 Drew More Than 2.7 Billion Visits to Global ePharmacies in 96 Countries in Q1'21
2021-07-01 16:23 Philip Morris International Announces Agreement to Acquire Fertin Pharma
2021-07-01 14:10 Ferring Pharmaceuticals Announces Changes to Board of Directors
2021-07-01 13:58 World Vapers’ Alliance: Back Vaping to Beat Smoking and to Save 200 Million Lives

Business Wire Weibo

Press Releases

Latest Releases